Abstract
Estrogen receptor (ER) assays in human breast cancer tissue have proved useful in selecting patients for endocrine therapies. The absence of ER indicates hormone independent tumors and precludes the use of endocrine therapy. Patients with positive tumor ER respond to endocrine therapy at nearly twice the rate of those patients chosen by clinical criteria, although about a third of ER positive tumors in patients still do not respond. Recently, research has been directed toward increasing the accuracy of the ER assay in the ER positive group. The absolute tumor ER value and the presence of progesterone receptor appear promising in this regard. The significance of nuclear estrogen receptor is being studied. Finally, the ER status of a primary breast tumor appears to be a marker for the length of time until recurrence after mastectomy, and for survival. The ER assay may prove valuable in planning new adjuvants in the treatment of breast cancer.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- FOLCA P. J., GLASCOCK R. F., IRVINE W. T. Studies with tritium-labelled hexoestrol in advanced breast cancer. Comparison of tissue accumulation of hexoestrol with response to bilateral adrenalectomy and oophorectomy. Lancet. 1961 Oct 7;2(7206):796–798. doi: 10.1016/s0140-6736(61)91088-1. [DOI] [PubMed] [Google Scholar]
- GLASCOCK R. F., HOEKSTRA W. G. Selective accumulation of tritium-labelled hexoestrol by the reproductive organs of immature female goats and sheep. Biochem J. 1959 Aug;72:673–682. doi: 10.1042/bj0720673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Knight W. A., Livingston R. B., Gregory E. J., McGuire W. L. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res. 1977 Dec;37(12):4669–4671. [PubMed] [Google Scholar]
- McGuire W. L., Horwitz K. B., Zava D. T., Garola R. E., Chamness G. C. Hormones in breast cancer: update 1978. Metabolism. 1978 Apr;27(4):487–501. doi: 10.1016/0026-0495(78)90103-8. [DOI] [PubMed] [Google Scholar]
- Rosen P. P., Menendez-Botet C. J., Nisselbaum J. S., Urban J. A., Miké V., Fracchia A., Schwartz M. K. Pathological review of breast lesions analyzed for estrogen receptor protein. Cancer Res. 1975 Nov;35(11 Pt 1):3187–3194. [PubMed] [Google Scholar]
- Singhakowinta A., Potter H. G., Buroker T. R., Samal B., Brooks S. C., Vaitkevicius V. K. Estrogen receptor and natural course of breast cancer. Ann Surg. 1976 Jan;183(1):84–88. doi: 10.1097/00000658-197601000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]